PMID- 24146937 OWN - NLM STAT- MEDLINE DCOM- 20140814 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 10 DP - 2013 TI - Long-term potentiation promotes proliferation/survival and neuronal differentiation of neural stem/progenitor cells. PG - e76860 LID - 10.1371/journal.pone.0076860 [doi] LID - e76860 AB - Neural stem cell (NSC) replacement therapy is considered a promising cell replacement therapy for various neurodegenerative diseases. However, the low rate of NSC survival and neurogenesis currently limits its clinical potential. Here, we examined if hippocampal long-term potentiation (LTP), one of the most well characterized forms of synaptic plasticity, promotes neurogenesis by facilitating proliferation/survival and neuronal differentiation of NSCs. We found that the induction of hippocampal LTP significantly facilitates proliferation/survival and neuronal differentiation of both endogenous neural progenitor cells (NPCs) and exogenously transplanted NSCs in the hippocampus in rats. These effects were eliminated by preventing LTP induction by pharmacological blockade of the N-methyl-D-aspartate glutamate receptor (NMDAR) via systemic application of the receptor antagonist, 3-[(R)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid (CPP). Moreover, using a NPC-neuron co-culture system, we were able to demonstrate that the LTP-promoted NPC neurogenesis is at least in part mediated by a LTP-increased neuronal release of brain-derived neurotrophic factor (BDNF) and its consequent activation of tropomysosin receptor kinase B (TrkB) receptors on NSCs. Our results indicate that LTP promotes the neurogenesis of both endogenous and exogenously transplanted NSCs in the brain. The study suggests that pre-conditioning of the host brain receiving area with a LTP-inducing deep brain stimulation protocol prior to NSC transplantation may increase the likelihood of success of using NSC transplantation as an effective cell therapy for various neurodegenerative diseases. FAU - Cho, Taesup AU - Cho T AD - Brain Research Centre and Department of Medicine, University of British Columbia, Vancouver, Canada. FAU - Ryu, Jae K AU - Ryu JK FAU - Taghibiglou, Changiz AU - Taghibiglou C FAU - Ge, Yuan AU - Ge Y FAU - Chan, Allen W AU - Chan AW FAU - Liu, Lidong AU - Liu L FAU - Lu, Jie AU - Lu J FAU - McLarnon, James G AU - McLarnon JG FAU - Wang, Yu Tian AU - Wang YT LA - eng GR - Canadian Institutes of Health Research/Canada GR - Howard Hughes Medical Institute/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131017 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/pharmacology MH - CA1 Region, Hippocampal/cytology/metabolism MH - *Cell Differentiation/drug effects MH - Cell Proliferation/drug effects MH - Cell Separation MH - Cell Survival/drug effects MH - Cells, Cultured MH - Coculture Techniques MH - Dentate Gyrus/cytology MH - HEK293 Cells MH - Humans MH - Long-Term Potentiation/drug effects/*physiology MH - Neural Stem Cells/*cytology/drug effects/metabolism/transplantation MH - Neurogenesis/drug effects MH - Neurons/*cytology/drug effects/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Receptor, trkB/metabolism MH - Receptors, N-Methyl-D-Aspartate/metabolism MH - Stem Cell Transplantation PMC - PMC3798289 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/10/23 06:00 MHDA- 2014/08/15 06:00 PMCR- 2013/10/17 CRDT- 2013/10/23 06:00 PHST- 2013/05/14 00:00 [received] PHST- 2013/08/28 00:00 [accepted] PHST- 2013/10/23 06:00 [entrez] PHST- 2013/10/23 06:00 [pubmed] PHST- 2014/08/15 06:00 [medline] PHST- 2013/10/17 00:00 [pmc-release] AID - PONE-D-13-19862 [pii] AID - 10.1371/journal.pone.0076860 [doi] PST - epublish SO - PLoS One. 2013 Oct 17;8(10):e76860. doi: 10.1371/journal.pone.0076860. eCollection 2013.